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Abstract
The C-terminus of the Helicobacter pylori CagA protein is polymorphic, bearing different EPIYA sequences (EPIYA-A, B, C or D), and
one or more CagA multimerization (CM) motifs. The number of EPIYA-C motifs is associated with precancerous lesions and gastric
cancer (GC). The relationship between EPIYA, CM motifs and gastric lesions was examined in H. pylori-infected Colombian patients
from areas of high and low risk for GC. Genomic DNA was extracted from H. pylori strains cultured from gastric biopsies from 80
adults with dyspeptic symptoms. Sixty-seven (83.8%) of 80 strains were cagA positive. The 3¢ region of cagA was sequenced, and EPIYA
and CM motifs were identified. CagA proteins contained one (64.2%), two (34.3%) or three EPIYA-C motifs (1.5%), all with Western
type CagA-specific sequences. Strains with one EPIYA-C motif were associated with less severe gastric lesions (non-atrophic and multi-
focal atrophic gastritis), whereas strains with multiple EPIYA-C motifs were associated with more severe lesions (intestinal metaplasia
and dysplasia) (p <0.001). In 54 strains, the CM motifs were identical to those common in Western strains. Thirteen strains from the
low-risk area contained two different CM motifs: one of Western type located within the EPIYA-C segment and another following the
EPIYA-C segment and resembling the CM motif found in East Asian strains. These strains induced significantly shorter projections in
AGS cells and an attenuated reduction in levels of CagA upon immunodepletion of SHP-2 than strains possessing Western/Western
motifs. This novel finding may partially explain the difference in GC incidence in these populations.
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Introduction
Helicobacter pylori is a spiral, Gram-negative microaerophilic
pathogenic bacterium that chronically colonizes the gastric
epithelium of approximately one-half of the world’s popula-
tion. In most infected subjects, this bacterium survives for
decades without clinically apparent consequences for the
host, especially in affluent populations with low risk for
gastric cancer (GC). However, in a fraction of infected
subjects, gastric inflammation induced by H. pylori can
progress to peptic ulceration, mucosa-associated lymphoid
tissue lymphoma, or gastric adenocarcinoma [1,2]. An
H. pylori virulence factor that is associated with more severe
disease is the cagA gene [1].
cagA encodes a 120- to 145-kDa CagA protein, and is a
marker for the cag pathogenicity island [3–5]. Many molecu-
lar epidemiological studies have shown that cagA-positive
H. pylori strains are associated with an increased risk of GC
[1,6,7]. cagA-positive H. pylori strains are associated with the
progression of inflammatory changes in the gastric mucosa
that may lead to GC: severe non-atrophic gastritis, atrophic
gastritis, intestinal metaplasia, and dysplasia [8]. Following
bacterial attachment and injection of CagA into the epithelial
cell by the type IV secretion system [9,10], the protein local-
izes to the inner surface of the plasma membrane and under-
goes tyrosine phosphorylation at Y-972, Y-899 and Y-912,
which is mediated by Ab1 and Src family kinases [11–14].
Phosphorylation of CagA at Y-972 has a function in actin-
based cytoskeletal rearrangements [11]. Once phosphory-
lated, CagA binds to a cytoplasmic Src Homology 2 (SH2)
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domain of Src Homology 2 phosphatase (SHP-2). Because
CagA–SHP-2 complexes disrupt signal transduction pathways
of the cell, the complexes may be involved in the develop-
ment of atrophic gastritis and the transition from atrophy to
intestinal metaplasia [15].
CagA proteins isolated from different H. pylori strains
exhibit sequence polymorphisms and duplications, especially in
their C-terminal regions containing EPIYA (glutamic acid-
proline-isoleucine-tyrosine-alanine) motifs [4]. Based upon
sequences surrounding those motifs, the segments are
designated as EPIYA-A, EPIYA-B, EPIYA-C or EPIYA-D [16].
EPIYA-A and EPIYA-B motifs are present in the CagA proteins
of almost all isolates of H. pylori of Western and East Asian
origin. The EPIYA-C motif, typically present in one to three
copies, is characteristic of CagA proteins from strains isolated
in European countries, the Americas and Australia. The
EPIYA-C segments also contain a sequence designated as
Western CagA-specific sequence (WSS) [17]. CagA proteins
carried by most Western H. pylori isolates have a single
EPIYA-C segment, and thus are classified as ABC types
[16,18]. However, some CagA proteins contain two or three
EPIYA-C motifs, and are termed ABCC or ABCCC types.
CagA proteins from strains isolated in East Asian countries do
not possess a WSS, but instead possess an East Asian
CagA-specific sequence (ESS) located within an EPIYA-D
segment [16–18]. The EPIYA-C and EPIYA-D motifs contain
the major tyrosine phosphorylation sites of CagA. Among
Western CagA species, the number of EPIYA-C sites is
directly related to levels of CagA tyrosine phosphorylation,
SHP-2 binding activity, and cytoskeletal alterations known as
the ‘hummingbird phenotype’ [16,19]. This finding suggests
that Western CagA proteins possessing a greater number of
EPIYA-C motifs are more virulent and thus more carcinogenic
than those having a smaller number of EPIYA-C motifs [13]. A
recent study of South African subjects revealed that five of six
Western-type H. pylori strains from gastric carcinoma patients
possessed multiple EPIYA-C sites, compared with only one of
19 strains from non-cancer patients [20]. Yamaoka et al. found
a significant association between the EPIYA-C motifs in
triplicate and gastric atrophy and intestinal metaplasia among
H. pylori isolates from Colombian patients [18].
A prerequisite for CagA–SHP-2 interaction is CagA multi-
merization, which is mediated by a conserved sequence of
16 amino acids (FPLXRXXXVXDLSKVG) recently identified
and designated as the CagA multimerization (CM) motif [21].
Eleven of the 16 amino acids in the CM motif are well con-
served between Western and East Asian CagA species.
Western CagA strains possess multiple CM motifs, located
within each EPIYA-C segment, plus one CM motif distal to
the last EPIYA-C, whereas East Asian CagA strains possess a
single CM motif, located distal to the EPIYA-D segment. The
type and number of CM motifs may influence the potential
of individual CagA proteins to multimerize in host cells, and
this may affect the ability of CagA to disturb host cell func-
tion via SHP-2 deregulation [21].
Previously we examined H. pylori strains isolated from sub-
jects living in two areas of Southwestern Colombia, which
differ markedly in GC incidence. Residents of Andean
regions such as Tuquerres are of mixed Native American
and Spanish ancestry, and are mainly farmers. This population
has a high incidence of GC. In contrast, residents of the Paci-
fic coast are of mixed African and Spanish ancestry, and have
a low risk of GC; their economy is based primarily on fish-
ing. We found that infection with H. pylori occurs at an early
age in both populations [22], but that the Andean residents
have a higher prevalence of more virulent (cagA+, vacA
s1m1) strains [23,24]. We asked whether these two popula-
tions might also harbour H. pylori strains that differed in cagA
3¢ end sequences encoding EPIYA or CM motifs and whether
those differences would be associated with the severity of
the gastric precancerous lesions.
Materials and Methods
Subjects
Male subjects, 39–60 years old, with dyspeptic symptoms,
who underwent upper gastrointestinal tract endoscopy, were
recruited in 2006 from the two areas with contrasting GC
risks in the State of Narin˜o, Colombia. According to our
previous observations in these populations, we expected
men of this age group to have high prevalence of H. pylori
infection and of preneoplastic lesions. Exclusion criteria were
previous gastrectomy, serious chronic diseases, or ingestion
of H2-receptor antagonists, proton pump inhibitors, or anti-
microbials in the 4 weeks prior to the endoscopic proce-
dure. Upper gastrointestinal tract endoscopy was performed
by an experienced gastroenterologist. Gastric mucosa biopsy
samples were obtained from the antrum, incisura angularis,
and corpus, and embedded in paraffin for histology. One
additional antral biopsy for H. pylori culture was immediately
frozen in glycerol and thioglycolate. The samples were
shipped on dry ice to Vanderbilt University (Nashville, TN,
USA) for analysis. Eighty subjects, from whom H. pylori could
be isolated, were included in this study. Forty-one individuals
(51.3%) were residents of Tuquerres, in the Andes Moun-
tains, where the GC incidence is high, and 39 (48.7%) were
residents of Tumaco, on the Pacific coast, where the GC
incidence is low. Persons performing molecular analyses and
histopathological assessments of biopsies were unaware of
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the diagnoses and residency of the patients. Ethics
committees of the two local hospitals and of the Universidad
del Valle in Cali, Colombia, approved the protocol for this
study. All participants provided informed consent.
Isolation and culture of H. pylori strains
Antral biopsy specimens were homogenized under sterile
conditions in 100 lL of sterile phosphate-buffered saline
(PBS, pH 7.4) using a homogenizer (Kimble-Kontes, Vineland,
NJ, USA). The homogenate was plated onto selective Trypti-
case soy agar (TSA) with 5% sheep blood containing vanco-
mycin (20 mg/L), bacitracin (200 mg/L), nalidixic acid (10 mg/
L) and amphotericin B (2 mg/L) (Sigma, St Louis, MO, USA),
and a 1:10 dilution was plated on a TSA plate (BBL;
LABSCO, Nashville, TN, USA) with no antibiotic. Agar plates
were incubated under microaerobic conditions (6% O2, 6%
CO2 and 88% N2; Campy Pak Plus envelope, BBL) at 37C
from 4 to 8 days until small grey translucent colonies
appeared. Gram stains and assays for oxidase and urease
were performed. Colony morphology was consistent with
the characteristic shape of H. pylori colonies. Swabs and sin-
gle colonies were used for DNA extraction.
Helicobacter pylori DNA extraction
DNA was extracted from bacterial pellets using Gentra
Puregene reagents, according to the manufacturer’s instruc-
tions (Qiagen, Valencia, CA, USA). DNA from H. pylori refer-
ence strains 26695 (ATCC 700392), J99 (ATCC 700824) and
Tx30a (ATCC 51932) were prepared for use as positive and
negative controls for the presence of cagA. Quantification of
DNA from all strains was performed spectrophotometrically.
PCR analysis
The primers used to amplify the 3¢ region of the cagA gene
were CAG1 (sense: 5¢-ACC CTA GTC GGT AAT GGG
TTA-3¢) and CAG2 (anti-sense: 5¢-GTA ATT GTC TAG TTT
CGC-3¢) [17], resulting in generation of fragments varying
from 591 to 856 bp. PCR mixtures consisted of 10 mM Tris–
HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 300 lM of each
dNTP, 0.3 lmol of each primer, and 0.1 U of Taq DNA Poly-
merase (Sigma) in a final volume of 35 lL. Three microlitres
of DNA extracted from the culture of the single colony was
added to each reaction mixture as template. The PCR pro-
gram for cagA amplification was as follows: 35 cycles consist-
ing of 1 min at 95C, 1 min at 50C, and 1 min at 72C, plus
a final 7-min extension step at 72C. PCR products (10 lL of
each sample) were separated by electrophoresis through 2%
agarose gels for 2 h at 60 V. To test for false-negative results
due to variation in sequences hybridizing with primers, we
employed a second, independent set of primers to determine
the presence of cagA (cagAF: 5¢-TTG ACC AAC AAC CAC
AAA CCG AAG-3¢; and cagAR: 5¢-CTT CCC TTA ATT
GCG AGA TTC C-3¢) [25]. These primers amplify a 183-bp
fragment in the 5¢ end of the cagA gene. Positive and negative
reagent control reactions, including a no-template control,
were included in each amplification.
DNA sequence analysis
PCR products were purified using Microcon YM-100 Centrif-
ugal Concentrators (Millipore Corp., Bedford, MA, USA).
Sequencing was performed using BigDye terminator chemis-
try with an ABI 3730xl DNA Analyzer. Sequencing primers
were the same as those used for PCR amplification. All cagA
sequences were compared with sequences of reference WSS
and ESS strains: H. pylori NCTC 11637 (GenBank AF202973),
H. pylori 26695 (GenBank AE000511), H. pylori J99 (GenBank
AE001439), H. pylori GC401 (F32) (GenBank AF202972), and
H. pylori strain N364 (kindly provided to us by T. Ando from
Nagoya, Japan). Sequence construction and alignment, as well
as translation were performed using GENEIOUS software, ver-
sion 2.5.3. (Biomatters, Auckland, New Zealand). The individ-
uals performing all the genotyping and sequencing reactions
were blinded to the location of residence of the subjects
whose samples they were analysing.
Histopathology
Histopathological diagnoses for each participant were inde-
pendently assessed by two experienced pathologists
(P.C. and M.B.P.) in H&E-stained sections from antrum,
incisura angularis and corpus, according to the updated
Sydney System classification [26], and to the Padova interna-
tional classification for dysplasia [27]. The categories were
non-atrophic gastritis (NAG), multifocal atrophic gastritis
without intestinal metaplasia (MAG), intestinal metaplasia
(IM), and dysplasia. NAG or MAG were considered less
severe lesions, and IM or dysplasia were considered more
severe lesions. Cases with discordant diagnoses were
reviewed in a double-headed microscope and a consensus
was reached. The presence of H. pylori was assessed histo-
logically by using a modified Steiner silver stain.
Induction of cell morphological changes
AGS cells were distributed into six-well plates at a density of
cells of the GC line AGS 5 · 105 cells/well and allowed to
adhere at 37C in a 5% CO2 air-humidified atmosphere
overnight.
Infection with 13 H. pylori strains (seven containing Wes-
tern/Western and six containing Western/East Asian CM
motifs) was performed at a concentration 100:1 (bacteria-
to-cell ratio) followed by 24 h of incubation. Uninfected AGS
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cells as well as cells infected with cagA-positive (VT-2) and
cagA-negative (Tx30a) H. pylori strains were used as controls.
Cells were examined for the hummingbird phenotype by
microscopy by two independent readers (L.S. and M.B.P.).
The lengths of cytoskeletal projections were assessed on
100 consecutive hummingbird cells in randomly selected
fields. We defined a hummingbird cell as a cell having a cellu-
lar needle-like protrusion >5 lm in length.
SHP-2 immunoprecipitation/immunodepletion and
Western blot
AGS cells were co-cultured for 6 h with ten H. pylori strains
(four containing Western/Western and six containing
Western/East Asian CM motifs) at a 100:1 bacteria-to-cell
ratio. H. pylori pellets (controls) and AGS cells at the end of
co-culture were lysed in RIPA lysis buffer (50 mM Tris–HCl,
pH 7.2/150 mM NaCl/1% Triton X-100/0.1% SDS). In order
to determine whether there were differences in complex
formation with SHP-2 and translocated CagA from different
H. pylori strains, in preliminary experiments we performed
co-immunoprecipitation assays with antibodies against SHP-2
and against CagA. However, sequential immunoprecipita-
tion–Western blot analysis using those two antibodies in
either order produced signal artefacts. Therefore, as an
alternative method to assess SHP-2 and CagA complex for-
mation, we performed immunodepletion assays using anti-
SHP-2 antibodies in which we immunodepleted SHP-2 from
the lysates and assessed whether there was concomitant
depletion of the translocated CagA from the lysates. The
lysates of AGS cells co-cultured with H. pylori were immun-
odepleted of SHP-2 by addition of SHP-2 antibody (Cell
Signaling Technology, Inc., Danvers, MA, USA), and protein
A/G plus agarose beads (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). The pre- and post-SHP-2-immunodepleted
lysates were resolved by SDS–PAGE and electrotransferred
to nitrocellulose membranes. The membranes were then
blotted with mouse anti-CagA monoclonal antibodies
(1:3000; Austral Biologicals, San Ramon, CA, USA) and goat
IgG-HRP anti-mouse antibodies (Santa Cruz Biotechnology).
To determine the extent of removal of CagA–SHP-2 com-
plexes by the anti-SHP-2 antibody, we then performed den-
sitometric analysis of the CagA bands with and without
immunodepletion by the anti-SHP-2 antibody. Blots were
developed using ECL detection reagents (Perkin Elmer LAS,
Inc., Boston, MA, USA). Densitometric analysis of protein
band density was performed on the X-ray films using IMAGEJ
software. The relative extents of immunodepletion were
calculated by dividing the pre-immunodepletion CagA band
density by the post-immunodepletion CagA band, and the
corrected band densities were calculated by dividing the
pre-immunodepletion CagA band densities by the band den-
sity of a CagA standard loaded for each PAGE gel.
In order to evaluate the amount of CagA protein that had
been phosphorylated by the AGS cell kinases (evidence of
translocation), after stripping the blots, we blotted with mouse
anti-phosphotyrosine PY-99 antibodies (1:300; Santa Cruz Bio-
technology) and goat IgG-HRP anti-mouse antibodies (Santa
Cruz Biotechnology). Detection of bound antibodies was per-
formed as above for blotting with the anti-CagA antibody.
Statistics
v2, Fisher’s exact and Student’s t-tests were used as appro-
priate to assess the statistical significance of the differences
in age, H. pylori status and variants of CagA in the risk area
and for the histological diagnosis. Statistical analyses for hum-
mingbird phenotype assessment were performed using linear
fixed effects models. Data were analysed using STATA 9.2
(Stata Corp., College Station, TX, USA).
Results
Histopathology
Among the 80 participants, 34 (42.5%) were classified as hav-
ing NAG, 14 (17.5%) as having MAG, 29 (36.3%) as IM, and
two cases (2.5%) were diagnosed as having dysplasia (display-
ing characteristics of the category ‘indefinite for dysplasia’
[27]). A subject with gastritis (1.2%), in which atrophy was
impossible to assess, was excluded from the majority of the
analyses. The distribution of cases according to histopatho-
logical diagnoses according to area is shown in Table 1.
TABLE 1. Status of Helicobacter pylori infection and
histopathological diagnoses in Colombian subjects
Variables
Low risk for
gastric cancer
n = 39
High risk for
gastric cancer
n = 41
Two-tailed
p valuea
Age in years, mean (SD) 48.1 (6.0) 49.7 (4.4) 0.174
H. pylori detection by
silver stain, n (%)
Negative 1 (2.6) 3 (7.3) 0.616
Positive 38 (97.4) 38 (92.7)
cagA3¢end assessment
by PCR, n (%)
Negative 7 (18.0) 6 (14.6) 0.688
Positive 32 (82.0) 35 (85.4)
Histopathological
diagnosisb, n (%)
NAG 21 (55.3) 13 (31.7) 0.034
MAG 6 (15.8) 8 (19.5)
IM 9 (23.7) 20 (48.8)
Dysplasia 2 (5.2) 0
SD, standard deviation; NAG, non-atrophic gastritis; MAG, multifocal atrophic
gastritis without intestinal metaplasia; IM, intestinal metaplasia.
ap value from v2, Fisher’s exact or t-tests as appropriate.
bA subject with gastritis in which we could not assess atrophy was excluded
from this analysis.
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NAG was more frequent in men from the low-risk area
(55.3%), whereas IM was most common in those from the
high-risk area (48.8%). Overall differences in distribution of
histopathological diagnoses according to area were signifi-
cant, revealing a prevalence of more advanced lesions in the
high-risk area for GC (p 0.034). H. pylori infection was highly
prevalent (>90%) in subjects from both areas. Histological
examination of the silver-stained sections of gastric biopsy
specimens showed the presence of typical spiral-shaped
H. pylori in 76 (95%) of the 80 cases and in 63 of 67 biopsy
specimens from patients infected with cagA-positive strains
(94%).
Detection of 3¢ variable region of the cagA gene
Amplification of the 3¢ end of cagA from 80 DNA samples
from cultured H. pylori strains generated fragments ranging
from 591 to 856 bp in 67 subjects, indicating cagA-positive
infection in those patients (83.8%; Table 1). All sequences
from those fragments aligned well with the cagA 3¢ ends of
strains 26695 and NCTC 11637. Amplification of DNA from
strains from the other 13 subjects did not generate cagA 3¢
end fragments, and those subjects were considered cagA neg-
ative and excluded from further molecular examinations. The
results of amplification of the smaller cagA fragment (183 bp)
in all 80 samples agreed completely with the results from
amplification of the 3¢ end of the gene. The prevalence of
cagA-positive strains was slightly higher in patients from the
high-risk area compared with those from the low-risk region;
however, this difference was not statistically significant
(p 0.688; Table 1).
Characterization of the C-terminal variable region by
EPIYA motif
Analysis of DNA and of predicted protein sequences
revealed that in 43 (64.2%) of 67 strains, the fragment desig-
nated as ‘short’ (591–654 bp) encoded three EPIYA motifs in
an ABC arrangement (Table 2 and Fig. 1). The shortest frag-
ment (591 bp) encoded two EPIYAs in an arrangement of
BC type, missing entirely the EPIYA-A segment. All 43 strains
which produced a short fragment included a single EPIYA-C
motif, as shown in Table 2.
In the other 24 strains, the C-terminal region was longer
than 654 bp and encoded two or three EPIYA-C motifs. The
shortest fragment of 693 bp was missing sequences encoding
the WSS motif in the first EPIYA-C segment. In all other
Colombian strains, each EPIYA-C segment contained a WSS.
Twenty-three of 24 long fragments encoded two EPIYA-C
motifs in an ABCC, ABCBC (856 bp) or ABBCC (772 bp)
pattern (Fig. 1; Table 2). The ABCBC fragment included a
sequence encoding an insert of 28 amino acids characteristic
of a B segment. The pattern of 772 bp was designated
ABBCC as it encoded a peptide with an insert of 19 amino
acids between EPIYA-A and EPIYA-B. One of 24 long frag-
ments included a sequence encoding five EPIYA motifs
assembled in an ABCCC pattern (850 bp; Fig. 1; Table 2)
possessing three EPIYA-C motifs. Patterns of the cagA 3¢ end
fragments in H. pylori strains and their frequency are shown
in Fig. 1. Nucleotide and predicted protein sequences of all
strains were deposited in GenBank, accession numbers
FJ542221–FJ542279.
Number of EPIYA motifs and histopathology
We next investigated the relationship between the number
of EPIYA-C motifs or CagA types and histopathological diag-
noses in both high- and low-risk areas. H. pylori strains with
TABLE 2. Number of EPIYA-C motifs according to
histopathological diagnoses by area of risk for gastric cancer
Risk areas
for gastric
cancer and
diagnoses
Number of EPIYA-C
motifs/CagA type
Two-tailed
p valuea1/ABC
2/ABCC,
ABCBC,
ABBCC 3/ABCCC
Total, n (%) n = 42b n = 23 n = 1
NAG 20 (47.6) 2 (8.7) 0 (0.00) <0.001/<0.001c
MAG 11 (26.2) 3 (13.0) 0 (0.00)
IM 11 (26.2) 16 (69.6) 1 (100.0)
Dysplasia 0 (0.00) 2 (8.7) 0 (0.00)
Low gastric cancer
risk, n (%)
n = 21 n = 10 n = 0
NAG 13 (62.0) 1 (10.0) – 0.007
MAG 4 (19.0) 2 (20.0) –
IM 4 (19.0) 5 (50.0) –
Dysplasia 0 (0.00) 2 (20.0) –
High gastric cancer
risk, n (%)
n = 21 n = 13 n = 1
NAG 7 (33.3) 1 (7.7) 0 (0.00) 0.026/0.012d
MAG 7 (33.3) 1 (7.7) 0 (0.00)
IM 7 (33.3) 11 (84.6) 1 (100.0)
ap-value for difference using a Fisher’s exact test.
bA subject with a strain ABC type and gastritis in which we could not assess
atrophy was excluded from this analysis.
cp-value if two and three EPIYA-C motifs were combined.
dp-value if two and three EPIYA-C motifs were combined.
NAG, non-atrophic gastritis; MAG, multifocal atrophic gastritis without intestinal
metaplasia; IM, intestinal metaplasia.
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FIG. 1. EPIYA-repeat polymorphisms in the C-terminal region of the
CagA protein and their frequency in the Colombian Helicobacter
pylori strains included in this analysis.
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only one EPIYA-C motif (ABC pattern) in the CagA proteins
were more frequently associated with NAG and MAG;
strains with two and three EPIYA-C motifs were more pre-
valent in subjects with IM and dysplasia, considering either
the total number of cases (p <0.001), or segregated by low-
(p 0.007) or high- (p 0.026) risk regions separately (Table 2).
The significance for the high-risk area was stronger when
two and three EPIYA-C motifs were combined (p 0.012,
Table 2). The number of H. pylori strains with one EPIYA-C
motif (ABC pattern), as well as strains with two and three
EPIYA-C motifs in their CagA protein, was not significantly
different in low- and high-risk areas (p 0.700; Table 3). No
EPIYA-D motifs were detected in our strains. One-half of
the Colombian strains carried CagA with a modified EPIYA-
B motif, with the threonine substituted for alanine as EPIYT
instead of EPIYA. However, we found no association
between EPIYA/EPIYT sequences and risk area (p 0.218) or
disease outcome (data not shown).
Characterization of the C-terminal variable region by CM
motif
In fifty-four of the 67 cagA-positive strains, the CM motifs
located within EPIYA-C segments and immediately distal to
the last repeat of the EPIYA-C segment had the peptide
sequence FPLKRHDKVDDLSKVG, typically found in H. pylori
strains from Western countries. Twenty-nine (69%) of 42
strains with three EPIYA motifs (ABC type, Table 3) con-
tained two identical Western CM motifs (Fig. 2a), and the
other 13 strains contained two different CM motifs (Fig. 2b;
GenBank accession numbers EU250990–EU251001). The CM
motif located within the EPIYA-C segment had the peptide
sequence found in strains from Western countries; the CM
motif located downstream of the EPIYA-C segment varied at
positions 4, 6, 7, 8 and 10, in the pattern FPLRRSAA
VEDLSKVG (two cases) and FPLRRSAKVEDLSKVG or
FPLRRSAKVDDLSKVG (11 cases). The CM motifs following
the EPIYA-C segment of the first two strains perfectly
matched the CM motifs from 87 strains isolated from
patients from East Asian countries (NCBI; Fig. 2c) and CM
motifs from reference strain F32 and Japanese strain N364
(Fig. 3). The CM motifs located after the EPIYA-C of the
other 11 strains exactly matched two clones of an H. pylori
strain from Mexico and seven H. pylori strains from Japan.
TABLE 3. Structural differences of the CagA protein of
Helicobacter pylori strains from two geographic areas
varying in risk for gastric cancer
Variables
Low risk
for gastric
cancer
High risk
for gastric
cancer
Two-tailed
p valuea
Number of EPIYA-C
motifs/CagA type, n (%)
n = 32 n = 35
1/ABCb 22 (68.8) 21 (60.0) 0.700
2/ABCC, ABBCC, ABCBC 10 (31.2) 13 (37.1)
3/ABCCC 0 (0) 1 (2.9)
CM motif in ABC CagA
type strains, n (%)
n = 21 n = 21
Two Western patterns 9 (42.9) 20 (95.2) <0.001
Western and East Asian patterns 12 (57.1) 1 (4.8)
Western-East Asian Combination
CM motifs and diagnoses, n (%)
n = 12 n = 1
NAG 7 (58.3) 0 0.462
MAG 2 (16.7) 0
IM 3 (25.0) 1 (100)
ap-value for difference using a Fisher’s exact test.
bOne of 43 strains of this classification was carrying only two EPIYAs.
NAG, non-atrophic gastritis; MAG, multifocal atrophic gastritis without intestinal
metaplasia; IM, intestinal metaplasia.
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FIG. 2. CagA multimerization (CM) motifs in
Colombian and Japanese Helicobacter pylori
strains: (a) Colombian H. pylori strain Co5054
possesses two identical Western CM motifs:
the first one is located in the N-terminal
region of the EPIYA-C segment and the
second one C-terminal to the EPIYA-C seg-
ment. (b) Colombian H. pylori strain Co5047
contains two different CM motifs: a Western
motif is located in the N-terminal region of
the EPIYA-C segment and an East Asian motif
is located C-terminal to the EPIYA-C segment.
(c) The Japanese H. pylori strain N364 contains
only one CM motif, an East Asian type located
C-terminal to the EPIYA-D segment.
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Because of the predominance of these CM motifs in strains
from Japan, China and Korea, we designated these CM
motifs as East Asian.
Twelve of 13 strains bearing both Western and East Asian
CM motifs were isolated from subjects from the low-risk
area (p <0.001 for sequence and area; Table 3) and nine of
those 12 (69.2%) were isolated from patients with less
severe gastric lesions (NAG and MAG). Four strains bearing
two different CM motifs were found in patients with IM
(30.8%). As the CM motif distribution differed in low- and
high-risk areas, we next determined if CM motifs were asso-
ciated with functional differences.
Hummingbird phenotype
We aimed to assess whether the type of CM motif in our
clinical ABC-type H. pylori strains was associated with the
extent of hummingbird change. We found that H. pylori
strains possessing Western/Western CM motifs were associ-
ated with a greater mean length (21.8 lm; 95% CI 20.7–
22.8) of hummingbird elongations compared with strains pos-
sessing Western/East Asian CM motif (18.3 lm; 95% CI
17.2–19.4, p <0.001).
Immunoprecipitation and Western blots
In Western blots with the anti-phosphotyrosine antibody,
phosphorylated CagA was detected in the same lysates as
CagA, suggesting internalization of CagA into the cytosol of
AGS cells (data not shown). We did not find any differences
in the frequency of translocation of the CagA from H. pylori
strains containing two different (one East-Asian and one
Western) CM motifs or two identical (two Western) CM
motifs: three out of six and two out of four CagAs were
translocated, respectively (Fig. 4, Table 4). Densitometric
analysis of the injected CagA demonstrated that the amounts
of CagA injected into AGS cells by strains with two identical
FIG. 3. Amino acid sequence characteristics of CagA C-terminal regions from six strains containing three EPIYA motifs. The reference strain
F32 and the strain N364 isolated from a Japanese patient contain an East Asian CagA-specific sequence (ESS) (underlined, thin line). The refer-
ence strain 26695 and strains Co5007, Co5047, Co5114 from Colombian patients contain a Western CagA-specific sequence (WSS) (underlined,
thick line). The amino acid sequences of Co5007 and Co5047 following the last EPIYA motif are similar to amino acid sequences in both Japa-
nese strains.
FIG. 4. Translocated CagA co-immunoprecipitates with SHP-2. AGS
cells were co-cultured with Helicobacter pylori strains 1–10 for 6 h.
Cell lysates were then immunodepleted of SHP-2 with an anti-SHP-2
antibody. Lysates with and without immunodepletion (SHP-2 ID)
were resolved by SDS–PAGE and protein levels were detected by
Western blotting. Strains 1, 2, 3, 4, 9 and 10 contain two different
CagA multimerization (CM) motifs in their CagA structure (one East
Asian and one Western); strains 5, 6, 7 and 8 contain two identical
(Western) CM motifs in their CagA structure.
TABLE 4. CagA internalization in AGS cells by Helicobacter
pylori strains possessing different CM motif type
H. pylori strains codes and
identification numbers
CM motif
type
CagA internalization
into AGS cells
1 – Co5004a W/E.A. +
2 – Co5029 W/E.A. )
3 – Co5021 W/E.A. +
4 – Co5034 W/E.A. +
5 – 26695b W/W )
6 – Co5068 W/W )
7 – Co5094 W/W +
8 – Co5058 W/W +
9 – Co5035 W/E.A. )
10 – Co5039 W/E.A. )
W/E.A., strains with one Western and one East Asian CM motifs in their CagA;
W/W, strains with two Western CM motifs in their CagA.
aCo, Colombian strain.
bReference H. pylori strain 26695 possessing two Western CM motifs in its
CagA.
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and two different CM motifs were comparable (average cor-
rected band density 3.9 and 4.6, respectively). Comparing
strains containing two different (one East Asian and one
Western) vs. two identical (two Western) CM motifs, we
found a quantitative difference in the amount of CagA that
was removed by the anti-SHP-2 antibody and therefore
complexed to SHP-2. There was an average 2.67-fold
decrease in CagA upon immunodepletion of SHP-2 in the
two Western CM motif samples, compared with an average
1.67-fold decrease in CagA in the strains having the East
Asian/Western CM motifs. This suggests that there is a
stronger affinity between CagA and SHP-2 from the Wes-
tern/Western CM motif strains compared with the East-
Asian/Western CM motif strains.
Discussion
In this study, we examined CagA C-terminal variations in
H. pylori strains from Colombian patients from two areas
with different GC risks. We found that the C-terminal
region varied considerably in size, from 591 to 856 bp, and
in number and structure of EPIYA and CM motifs. Encoded
in their cagA 3¢end, Colombian H. pylori strains had one to
three EPIYA-C motifs in an ABC, ABCC, ABCBC, ABBCC
or ABCCC CagA pattern. We also found both Western and
East Asian CM motifs in Colombian H. pylori strains contain-
ing WSS in their C-terminal CagA, and these variations were
associated with functional differences. Recent studies have
revealed much about the functional significance of variations
in the C-terminal portions of the CagA proteins from clinical
H. pylori isolates [13,28]. In co-culture experiments, the num-
ber of EPIYA-C motifs was directly correlated with levels of
tyrosine phosphorylation and SHP-2-binding activity among
Western CagA varieties [16,19,20]. Variations in the number
of tyrosine phosphorylation sites in the C-terminal of CagA
were associated with dephosphorylation and inactivation of
focal adhesion kinase, induction of the hummingbird pheno-
type, and deregulation of the SHP-2 oncoprotein [13,29,30].
The CM motif, which is variably duplicated among distinct
Western CagA species, may also disturb host cell function
via SHP-2 deregulation [21]. CagA variations, particularly in
the C-terminal region at the SHP-2 binding site, could affect
the potential of different strains of H. pylori to promote gas-
tric carcinogenesis [28]. We tested whether the number of
EPIYA-C motifs or the type of CM motifs was associated
with differences in GC risk in two Colombian areas.
We examined gastric mucosal lesions spanning multiple
stages of the gastric carcinogenesis cascade [31] and their
relationship to the number of EPIYA-C motifs. Our finding
of significant associations between two and three EPIYA-C
motifs in the CagA protein with more severe lesions is con-
sistent with identification of that variation as a virulence mar-
ker in strains isolated from South Africa, Japan, Korea, and
the central region of Colombia [17,18,20,32]. The propor-
tion of strains bearing two (34.3%) and three (1.5%) EPIYA-
C sites appeared to be higher in our population of strains
than previously reported in Mexican H. pylori strains (30%;
[33]) or in Peruvian ones (11.5%; [34]). In the Peruvian
study, the majority of variants contained one, rarely two, but
not three EPIYA-C motifs. Of 33 H. pylori strains isolated in
Costa Rica (GeneBank AF289432–289464; [35]), 21 con-
tained one EPIYA-C, and 12 contained two EPIYA-C motifs.
No strains contained three or more EPIYA-C motifs. By con-
trast, in a study of isolates from Colombian subjects,
Yamaoka et al. [18] found that 9.5% of the H. pylori strains
contained three or more EPIYA-C motifs, but this difference
could be due to the selection of patients with different diag-
noses, as almost half of their patients had GC, whereas the
others had chronic gastritis and duodenal ulcer disease. No
H. pylori strains in this study contained an EPIYA D motif
despite their isolation from a Native American population
with ancestry in East Asia.
In our previous studies of the well-established virulence
markers of H. pylori (presence or absence of cagA, vacA s and
m regions), we found a higher proportion of more virulent
strains (cagA+, vacA s1/m1) in the Colombian region of high
risk for GC [23,24]. In the present study, the distribution of
strains with one, two and three EPIYA-C motifs was not sig-
nificantly different in the two areas, suggesting the CagA type
is not the cause of different GC incidence rates in those two
areas. Other cagA 3¢ end variations or other bacterial viru-
lence factors, other genetic or environmental factors may be
responsible for the high incidence of GC in the Andean
regions of Colombia.
This report has revealed the diversity in the CM motifs of
H. pylori strains circulating in the state of Narin˜o, Colombia.
Although the number of H. pylori strains of ABC type CagA
was essentially equal in the two areas, we found different
types of CM motifs in ABC type strains from each area. We
found H. pylori strains bearing a CM motif described previ-
ously only in strains from East Asian countries (NCBI data-
base). Remarkably, the East Asian pattern of the CM motif
appeared in the majority of strains from subjects from the
low-risk area. Identification of CM sequences associated with
East Asian strains was unexpected in the low-risk region,
because those populations are characterized by African,
rather than Native American ancestry. In our study, the
presence of the East Asian CM motif was not associated
with the severity of gastric lesions. However, the majority of
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strains bearing a combination of one East Asian and one
Western CM motif were found in patients with less severe
lesions (NAG). In our in vitro experiments, immunoblotting
of CagA in lysates with and without SHP-2 immunodepletion
suggested that higher affinity CagA–SHP-2 complexes could
be formed by strains containing two Western CM motifs
compared with strains having two different CM motifs. In
parallel, more intense induction of hummingbird responses
were induced by strains containing two Western CM motifs
in their CagA compared with those possessing one Western
and one East Asian CM motif. These results suggest that the
East Asian CM motif in the Colombian, Western-type CagA
may be less functional in multimerization compared with the
Western CM motif. Altered multimerization potential of
CagA proteins in strains bearing two different CM motifs
may help to explain the prevalence of less severe pre-
malignant lesions (NAG) in the low-risk area. In vitro experi-
ments with isogenic mutants will be necessary to establish
this result unequivocally.
In conclusion, we have demonstrated that the 3¢ end of
the cagA gene and its CagA protein in Colombian H. pylori
strains is heterogeneous with respect to size, to the number
of EPIYA, WSS and CM motifs and the internal structure.
H. pylori strains with two and three EPIYA-C motifs were
associated with more severe gastric lesions. H. pylori strains
with two different CM motifs—one Western and one East
Asian—showed altered biological activity in vitro and were
found predominantly in patients with less severe gastric
lesions. This finding may partially explain the lower incidence
of GC on the Pacific coast of Colombia.
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